[go: up one dir, main page]

WO2001039741A3 - Mitomycin c solution - Google Patents

Mitomycin c solution Download PDF

Info

Publication number
WO2001039741A3
WO2001039741A3 PCT/EP2000/011903 EP0011903W WO0139741A3 WO 2001039741 A3 WO2001039741 A3 WO 2001039741A3 EP 0011903 W EP0011903 W EP 0011903W WO 0139741 A3 WO0139741 A3 WO 0139741A3
Authority
WO
WIPO (PCT)
Prior art keywords
mitomycin
solution
aqueous solution
relates
stable aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/011903
Other languages
German (de)
French (fr)
Other versions
WO2001039741A2 (en
Inventor
Hans-Peter Schroeer
Wilfried Mohr
Ferdinand Bach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Original Assignee
Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Gesellschaft fuer Klinische Spezialpraeparate mbH filed Critical Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Priority to AU26699/01A priority Critical patent/AU2669901A/en
Publication of WO2001039741A2 publication Critical patent/WO2001039741A2/en
Publication of WO2001039741A3 publication Critical patent/WO2001039741A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a stable aqueous solution of the cytostatic agent mitomycin C and to a mitomycin C containing medicament.
PCT/EP2000/011903 1999-11-29 2000-11-29 Mitomycin c solution Ceased WO2001039741A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU26699/01A AU2669901A (en) 1999-11-29 2000-11-29 Mitomycin C solution

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999157371 DE19957371A1 (en) 1999-11-29 1999-11-29 Mitomycin C solution
DE19957371.9 1999-11-29

Publications (2)

Publication Number Publication Date
WO2001039741A2 WO2001039741A2 (en) 2001-06-07
WO2001039741A3 true WO2001039741A3 (en) 2001-12-13

Family

ID=7930703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011903 Ceased WO2001039741A2 (en) 1999-11-29 2000-11-29 Mitomycin c solution

Country Status (3)

Country Link
AU (1) AU2669901A (en)
DE (1) DE19957371A1 (en)
WO (1) WO2001039741A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004009806A (en) 2002-06-04 2004-01-15 Ichikoh Ind Ltd Outer mirror for vehicles
PL2865391T3 (en) 2013-10-22 2018-01-31 Medac Ges Fuer Klinische Spezialpraeparate Mbh Method for producing a freeze-dried pharmaceutical composition containing Mitomycin C
IN202121042020A (en) * 2021-09-17 2023-03-24

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52151716A (en) * 1976-06-14 1977-12-16 Kyowa Hakko Kogyo Co Ltd Stabilization of mitomycin c

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004552A1 (en) * 1984-04-10 1985-10-24 Baxter Travenol Laboratories, Inc. Solutions of mitomycin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52151716A (en) * 1976-06-14 1977-12-16 Kyowa Hakko Kogyo Co Ltd Stabilization of mitomycin c

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEIJNEN J.H; VAN GIJN R; UNDERBERG W.J: "Chemical stability of the antitumor drug mitomycin C in solutions for intravesical instillation", JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY, vol. 44, no. 6, 1990, pages 332 - 335, XP001002008 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; KONDO, AKIRA ET AL: "Stabilizing aqueous mitomycin C", XP002169828, retrieved from STN Database accession no. 88:177234 *
STOLK L.M.L ET AL: "Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use", PHARMACEUTISCH WEEKBLAD SIENTIFIC EDITION, vol. 8, no. 6, 1986, pages 286 - 288, XP001002173 *

Also Published As

Publication number Publication date
DE19957371A1 (en) 2001-06-13
AU2669901A (en) 2001-06-12
WO2001039741A2 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
HK1042444A1 (en) A medicinal aerosol formulation
AU2002253619A1 (en) Heterocyclic compound and antitumor agent containing the same active ingredients
WO2002064210A3 (en) Combination therapy comprising anti-diabetic and anticonvulsant agents
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
IL161885A0 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
AU2001234114A1 (en) Drugs containing combined active ingredients
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU6440600A (en) Combination of active agents, said combination containing clonidine
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
AU2001286242A1 (en) Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
PL338844A1 (en) Stable aqueous solution of lysine
WO2001039741A3 (en) Mitomycin c solution
AU2023801A (en) Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient
AU778462C (en) Blood carbonyl compound-trapping agent
CA2388830A1 (en) Oral solution containing galanthamine and a sweetening agent
EP1142565A4 (en) Aqueous medicinal compositions
WO2002007672A3 (en) A medicinal aerosol formulation
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
HUP0203525A3 (en) Hygromycin derivatives, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP